Studies have shown that hypoallergenic, amino acid-based formulas can help manage clinical symptoms of eosinophilic esophagitis (EoE).1,2
Eosinophilic gastrointestinal disorders (EGIDs) are chronic digestive system disorders in which certain food proteins trigger an overproduction of eosinophils (white blood cells that help fight certain infections) in different areas of the digestive tract.
EGIDs typically fall into one of three types:
Eosinophilic esophagitis (EoE): EoE is the most common and difficult type of EGID to manage. It is characterized by inflammation of the esophagus due to abnormally high levels of eosinophils in that area of the GI tract. Symptoms can include abdominal pain, diarrhea, nausea, severe vomiting, difficulty swallowing, and, at times, obstruction.
Eosinophilic gastroenteritis: Associated with eosinophils and inflammation in the stomach and small intestine
Eosinophilic colitis: Associated with eosinophils and inflammation in the large intestine
Common symptoms of EGIDs
How to manage EGIDs
Your doctor may be able to identify specific food proteins that trigger the overproduction of eosinophils in your child. Your doctor may recommend an elimination diet where the offending proteins are not consumed. Often a stricter diet — an amino acid-based diet — is prescribed.
How EleCare and EleCare Jr can help
The protein in EleCare and EleCare Jr is supplied by amino acids, the building blocks of proteins, instead of intact or hydrolyzed protein.
For more information about EGIDs, check out:
EleCare and EleCare Jr can also help with the dietary management of:
*Among those recommending amino acid-based products for infants and children ages 1 and up.
1. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: A 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198-1206.
2. Furuta GT, Liacouras CA, Collins MG, et al. Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-1363.